Institution
Children's Hospital of Wisconsin
Healthcare•Milwaukee, Wisconsin, United States•
About: Children's Hospital of Wisconsin is a healthcare organization based out in Milwaukee, Wisconsin, United States. It is known for research contribution in the topics: Population & Transplantation. The organization has 2157 authors who have published 3448 publications receiving 107246 citations.
Papers published on a yearly basis
Papers
More filters
Oregon Health & Science University1, University of Washington2, University at Buffalo3, University of Michigan4, University of California, San Diego5, University of Iowa Hospitals and Clinics6, University of Cincinnati7, United States Department of Veterans Affairs8, Harvard University9, United States Department of the Army10, Walter Reed Army Medical Center11, University of Connecticut12, University of Colorado Denver13, Johns Hopkins University14, Veterans Health Administration15, Boston Children's Hospital16, University of Iowa17, University of Texas at Austin18, Virginia Mason Medical Center19, Thomas Jefferson University20, Seattle Children's21, Children's Hospital of Wisconsin22
TL;DR: The American Pain Society, with input from the American Society of Anesthesiologists, developed a clinical practice guideline to promote evidence-based, effective, and safer postoperative pain management in children and adults.
1,806 citations
TL;DR: This study documents ongoing survival improvements for children and adolescents with acute lymphoblastic leukemia, emphasizing that efforts to further improve survival must be directed at both high-risk subsets and at those children predicted to have an excellent chance for cure.
Abstract: Purpose To examine population-based improvements in survival and the impact of clinical covariates on outcome among children and adolescents with acute lymphoblastic leukemia (ALL) enrolled onto Children’s Oncology Group (COG) clinical trials between 1990 and 2005.
934 citations
University of Michigan1, University of Texas Southwestern Medical Center2, Harvard University3, National Institutes of Health4, University of Pennsylvania5, Children's Hospital of Wisconsin6, Duke University7, Wake Forest University8, East Carolina University9, University of Southern California10, University of Toronto11, Boston Children's Hospital12, Medical University of South Carolina13, University of Utah14, Alfred I. duPont Hospital for Children15, Emory University16, Cardinal Glennon Children's Hospital17
TL;DR: In children undergoing the Norwood procedure, transplantation-free survival at 12 months was better with the RVPA shunt than with the MBT shunt, and the rate of nonfatal serious adverse events at the age of 12 months were similar in the two groups.
Abstract: Background The Norwood procedure with a modified Blalock–Taussig (MBT) shunt, the first palliative stage for single-ventricle lesions with systemic outflow obstruction, is associated with high mortality. The right ventricle–pulmonary artery (RVPA) shunt may improve coronary flow but requires a ventriculotomy. We compared the two shunts in infants with hypoplastic heart syndrome or related anomalies. Methods Infants undergoing the Norwood procedure were randomly assigned to the MBT shunt (275 infants) or the RVPA shunt (274 infants) at 15 North American centers. The primary outcome was death or cardiac transplantation 12 months after randomization. Secondary outcomes included unintended cardiovascular interventions and right ventricular size and function at 14 months and transplantation-free survival until the last subject reached 14 months of age. Results Transplantation-free survival 12 months after randomization was higher with the RVPA shunt than with the MBT shunt (74% vs. 64%, P=0.01). However, the R...
751 citations
Dalhousie University1, Hackensack University Medical Center2, University of Washington3, University of Rochester Medical Center4, Pfizer5, Columbia University6, University of Bath7, Boston Children's Hospital8, National Institutes of Health9, Food and Drug Administration10, Uppsala University11, Oregon Health & Science University12, Merck & Co.13, AstraZeneca14, University of Toronto15, University of Saskatchewan16, Vanderbilt University Medical Center17, Children's Hospital of Wisconsin18, Endo International plc19, University of California, Los Angeles20
TL;DR: Based on systematic review and consensus of experts, core domains and measures for clinical trials to treat pain in children and adolescents were defined to assist in comparison and pooling of data and promote evidence-based treatment.
715 citations
TL;DR: The power of exome sequencing to render a molecular diagnosis in an individual patient in the setting of a novel disease, after all standard diagnoses were exhausted, is demonstrated and illustrates how this technology can be used in a clinical setting.
694 citations
Authors
Showing all 2181 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Mary M. Horowitz | 127 | 557 | 56539 |
| Russell A. Barkley | 119 | 355 | 60109 |
| Yang Shi | 102 | 309 | 46316 |
| Balaraman Kalyanaraman | 100 | 475 | 38562 |
| William Grossman | 97 | 307 | 33605 |
| Rohit Loomba | 87 | 646 | 29700 |
| Bruce M. Camitta | 83 | 326 | 23700 |
| Larry E. Kun | 80 | 339 | 23821 |
| Howard J. Jacob | 76 | 316 | 26404 |
| Raymond G. Hoffmann | 76 | 299 | 19810 |
| Jeff D. Williamson | 73 | 271 | 38119 |
| Subra Kugathasan | 67 | 267 | 22619 |
| Roy Patterson | 65 | 603 | 17147 |
| Robert R. Montgomery | 64 | 265 | 15057 |
| Carl L. Backer | 64 | 427 | 13004 |